Application 208964
- Type
- ANDA
- Sponsor
- LUPIN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOBRAMYCIN | TOBRAMYCIN | SOLUTION;INHALATION | 300MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68180-962 | Tobramycin | Tobramycin | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-962 | Tobramycin | Tobramycin | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-962 | Tobramycin | Tobramycin | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-962 | Tobramycin | Tobramycin | Lupin Pharmaceuticals, Inc. | ANDA | Current |